Core Viewpoint - The establishment of a joint venture, Jindawei (Inner Mongolia) Nutritional Food Co., Ltd., between Jindawei Pharmaceutical and Aibede Life Science Research Institute aims to enhance product absorption efficiency and competitiveness in the global market [1] Group 1 - The joint venture is located in the industrial park of Tokto County, Hohhot City, Inner Mongolia [1] - The collaboration will leverage nanocrystal production technology for products such as Coenzyme Q10, Astaxanthin, Curcumin, and Quercetin [1] - The application of this technology is expected to significantly improve the absorption speed and efficiency of the company's related products [1]

Core Viewpoint - The establishment of a joint venture, Jindawei (Inner Mongolia) Nutritional Food Co., Ltd., between Jindawei Pharmaceutical and Aibede Life Science Research Institute aims to enhance product absorption efficiency and competitiveness in the global market [1] Group 1 - Jindawei Pharmaceutical has received notification regarding the establishment of a joint venture in Hohhot, Inner Mongolia [1] - The joint venture will utilize nanocrystal production technology for products such as coenzyme Q10, astaxanthin, curcumin, and quercetin [1] - The application of this technology is expected to significantly improve the absorption speed and efficiency of the company's related products [1] Group 2 - The collaboration is intended to deepen cooperation between Jindawei and Aibede, benefiting both companies in the nutritional health sector for humans and pets [1] - The technology's implementation is anticipated to enhance the company's product competitiveness [1] - This initiative is aligned with the company's strategy to expand its business in the global market [1]

Core Viewpoint - The establishment of a joint venture between Jindawei Pharmaceutical and Aibede Life Science Research Institute aims to enhance the absorption efficiency of various health products through advanced nanocrystal production technology [1] Group 1: Joint Venture Details - Jindawei Pharmaceutical has received notification regarding the establishment of a joint venture with Aibede in Hohhot, Inner Mongolia [1] - The joint venture will focus on applying nanocrystal production technology to products such as Coenzyme Q10, Astaxanthin, Curcumin, and Quercetin [1] Group 2: Strategic Implications - The collaboration is expected to significantly improve the absorption speed and efficiency of the related products [1] - The applications of these enhanced products will extend to both human and pet nutritional health [1]